Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 231 to 240 of 335 resources

  • Measuring the impact of the recommendations of the London Joint Working Group on Substance Use and Hepatitis C - learning from the pilots
    In 2011 the London Joint Working Group published 'Tackling the Problem of Hepatitis C, Substance Misuse and Health Inequalities: a Consensus for London'. The document set out a number of recommendations to improve the integration of services in London for people with hepatitis C and a history of using drugs. In 2013 the group aimed to assess the impact of its recommendations by setting up a pilot project in four London boroughs.
    UK, England, Greater London May 2015 Case study, Other, Reports & Research, Strategy & Planning PDF
  • Midlands & East Hepatitis C Educational Event in Nottingham: Presentations
    On Friday 10th February 2017, HCV Action and NHS England held a Midlands & East Hepatitis C Educational Event in Nottingham. With hepatitis C Operational Delivery Networks (ODNs) still relatively new in operation, the event was held with the aim of offering the chance for ODNs across the Midlands and East region to come together to discuss their experiences, share best practice and develop solutions to some of the challenges they face as they seek to ensure the highest standards of hepatitis C care and treatment.
    UK, East Midlands Reports & Research MS Powerpoint
  • Midlands & East Hepatitis C ODN Educational Event 2018: Presentations
    The second Midlands & East Hepatitis C ODN Educational Event took place on Friday 9th March 2018 at the De Vere East Midlands Conference Centre in Nottingham. The event built on the success of the first Midlands & East Hepatitis C ODN Educational Event, which took place in February 2017. Hosted by HCV Action and NHS England, the event offered the chance for ODNs across the Midlands & East region to come together to share their experiences, highlight best practice and discuss challenges.
    England, East Midlands, East of England, West Midlands Reports & Research PDF
  • More Transplants, Saving More Lives: The Future for Organ Donation in the UK
    Over 1,000 people die each year waiting for an organ transplant in the UK because there is a national shortage of organ donations.
    UK 11 Mar 2008 Reports & Research PDF
  • National Clinical Guidelines for the treatment of HCV in adults
    These guidelines provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness.

    Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.
    Scotland Sep 2015 Other, Strategy & Planning PDF
  • National Clinical Guidelines for the treatment of HCV in adults
    These Scottish guidelines, updated in January 2016, provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness. Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.
    Scotland Jan 2017 Other, Strategy & Planning PDF
  • National survey of hepatitis C services in prisons in England, July 2012
    This is the first dedicated survey of hepatitis C services in prisons in England. The survey aim was to collect basic information on what type of services are provided in prisons for the diagnosis, treatment and follow-up of prisoners infected by hepatitis C.
    England Jul 2012 Reports & Research PDF
  • Needle Exchange Surveillance Initiative: 2008-9 to 2015-16
    The Needle Exchange Surveillance Initiative measures and monitorings the prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs in Scotland. This report presents the results, at the NHS board level, for the data collection period from February 2015 until March 2016. It also presents the findings of the NESI survey, at Scotland-wide level, from 2008-09 until the most recent survey, 2015-16.
    UK, Scotland Mar 2017 Reports & Research PDF
  • New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
    This article provides analysis of the estimated impact of new treatment for hepatitis C on both the prevention of transmission of the virus, and on preventing hepatitis C-related liver disease.

    It concludes that focusing treatment solely on people with cirrhosis is not a tenable long-term strategy if continued reductions in new cases of end stage liver disease and hepatocellular carcinoma, as well as reductions in transmission are to be achieved. It also finds that treatment of other groups will need to follow quickly if these reductions are to be achieved.
    England Apr 2016 Reports & Research PDF
  • New Treatments for Hepatitis C Virus: Strategies for Achieving Universal Access
    This report summarises the current global treatment landscape for hepatitis C. The authors highlight 2014 as a 'turning-point in the history of the pandemic', but emphasise the detrimental impact of pharmaceutical company marketing strategies in making universal access to treatment practically unachievable. Suggestions for improving treatment access are put forth based on an examination of the lessons learnt from the fight against HIV/AIDS.
    UK, Rest of World 2014 Reports & Research PDF

Pages